In a sector traditionally marked by high costs, long adaptation times, and limited customization, Limbium has burst onto the scene with a technological proposition that aims to change the rules of the game. This Spanish company specializes in the design and manufacture of customized arm prostheses, from bionic solutions to sports models and finger prostheses, with the aim of making technology more accessible—something decisive for many people in reclaiming autonomy and quality of life.
The origin of Limbium is tied to Murcia and, more specifically, to the innovative environment surrounding the Polytechnic University of Cartagena and the regional entrepreneurial ecosystem. According to the UPCT, Alberto Martínez Ramos, founder of the company, created the firm from his final degree project (TFG). That academic and technological starting point helps explain the startup’s DNA: a blend of engineering, applied development, and a clear intention to bring innovation to a very concrete problem—the needs of people who are amputated or born with arm agenesis and require functional solutions tailored to their case.
The company’s headquarters are in Espinardo, Murcia, at the European Center for Business and Innovation of Murcia (CEEIM), specifically in the CEEIM Building, on the University Campus. The company itself explains that it is there where it designs, develops, and manufactures its solutions, a location that reinforces its ties to the Murcian tech ecosystem and to a network supporting innovative entrepreneurship.
Limbium’s Proposal
Limbium’s proposal is based on technologies such as 3D design, additive manufacturing, and artificial intelligence. Its catalog includes a bionic arm, a sports prosthesis, and a finger prosthesis, all aimed at extreme customization according to the level of amputation, intended use, and the patient’s specific needs. The company also emphasizes the use of lightweight and durable materials, technical support, and the aim of lowering entry barriers through more efficient processes.
This innovative positioning has already earned several recognitions. The most notable to date arrived on March 5, 2026, when Limbium won the National Impulsa Startup Award 2025 from the Spanish Chamber (Cámara de España), in the final held at 4YFN, within the Mobile World Congress in Barcelona. The Chamber of Spain noted that the startup, founded in 2023, was chosen from more than 300 applications and received a prize of 12,000 euros.
For SMEs, orthopedic clinics, federations, and health-care professionals, Limbium’s case shows how a university-origin company based in Murcia can carve a path in a field of high technological complexity. Its evolution also points to a deeper trend: medical technology no longer competes solely on sophistication but on adaptability, speed of manufacturing, and proximity to the end user. In that space, the company is trying to establish its name with a simple idea to explain, yet difficult to execute: that a prosthesis is not just a device but a real tool to restore independence.
